IT1238011B - Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. - Google Patents

Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.

Info

Publication number
IT1238011B
IT1238011B IT04865889A IT4865889A IT1238011B IT 1238011 B IT1238011 B IT 1238011B IT 04865889 A IT04865889 A IT 04865889A IT 4865889 A IT4865889 A IT 4865889A IT 1238011 B IT1238011 B IT 1238011B
Authority
IT
Italy
Prior art keywords
hmg
treatment
prostatic hypertrophy
pharmaceutical composition
coa reductase
Prior art date
Application number
IT04865889A
Other languages
English (en)
Other versions
IT8948658A1 (it
IT8948658A0 (it
Inventor
Evaristo Bertone
Original Assignee
Pulitzer Italiana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pulitzer Italiana filed Critical Pulitzer Italiana
Priority to IT04865889A priority Critical patent/IT1238011B/it
Publication of IT8948658A0 publication Critical patent/IT8948658A0/it
Publication of IT8948658A1 publication Critical patent/IT8948658A1/it
Application granted granted Critical
Publication of IT1238011B publication Critical patent/IT1238011B/it

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT04865889A 1989-12-13 1989-12-13 Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. IT1238011B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT04865889A IT1238011B (it) 1989-12-13 1989-12-13 Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04865889A IT1238011B (it) 1989-12-13 1989-12-13 Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.

Publications (3)

Publication Number Publication Date
IT8948658A0 IT8948658A0 (it) 1989-12-13
IT8948658A1 IT8948658A1 (it) 1991-06-13
IT1238011B true IT1238011B (it) 1993-06-21

Family

ID=11267879

Family Applications (1)

Application Number Title Priority Date Filing Date
IT04865889A IT1238011B (it) 1989-12-13 1989-12-13 Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.

Country Status (1)

Country Link
IT (1) IT1238011B (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026300A1 (en) * 2002-09-17 2004-04-01 Pfizer Limited COMBINATIONS OF ATORVASTATIN AND α1, ADRENERGIC RECEPTOR ANTAGONISTS
WO2005089804A2 (en) * 2004-03-16 2005-09-29 Pfizer Limited Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026300A1 (en) * 2002-09-17 2004-04-01 Pfizer Limited COMBINATIONS OF ATORVASTATIN AND α1, ADRENERGIC RECEPTOR ANTAGONISTS
WO2005089804A2 (en) * 2004-03-16 2005-09-29 Pfizer Limited Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
WO2005089804A3 (en) * 2004-03-16 2006-05-18 Pfizer Ltd Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists

Also Published As

Publication number Publication date
IT8948658A1 (it) 1991-06-13
IT8948658A0 (it) 1989-12-13

Similar Documents

Publication Publication Date Title
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
ATE177949T1 (de) Kombinationstherapie zur prophylaxe und/oder behandlung benigner prostatahyperplasie
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
ES2128552T3 (es) Combinacion de un inhibidor de la biosintesis del colesterol y un inhibidor de la absorcion del colesterol beta-lactama.
GEP20033117B (en) Hydroxy Pipecolate Hydroxamic Acid Derivatives as MMP Inhibitors, Pharmaceutical Compositions Containing Them and Their Use for Treatment of Diseases caused by MMP
EA200001044A3 (ru) Соединения для лечения женской сексуальной дисфункции
HK1001973A1 (en) Sulfonamides
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
EE05025B1 (et) Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks
BR0110420A (pt) Agonistas muscarìnicos
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
HUP0000558A2 (hu) Aktív D-vitamin analógok alkalmazása prosztatabetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
TR199901604T2 (xx) Tedavide yararl� kinolin ve kinazolin bile�ikleri.
GEP20043322B (en) C7 Ester Substituted Taxanes as Antitumor Agents, Pharmaceutical Compositions Containing the Same and Use Thereof for Inhibiting Tumors
ATE212351T1 (de) Androsten-derivate
TR200100774T2 (tr) Bir aP2 önleyicisinin ve kombinasyonunun kullanıldığı aterosklerozis tedavi yöntemi
CY1111869T1 (el) Φαρμακευτικες συνθεσεις και μεθοδοι χρησιμες για την αντιμετωπιση του καρκινου ή της ηπατικης ινωσης
ATE156839T1 (de) Neue delta-17 und delta-20 ungesätigte und gesatigte 17--g(b)-substituierte-4-aza-5-g(a)- androstan-3-on verbindungen als inhibitoren von 5-alpha-reductase
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
MY118986A (en) Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
ZA971891B (en) Use of aryl N-substituted carboxamides directly and as radio- and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
IL150125A0 (en) Novel compounds
RS92304A (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for long-term preservation of acute urinary retention
HUP9801022A2 (hu) Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására
IT1238011B (it) Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961223